Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 OutlookZacks Investment Research • 06/03/25
3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in JuneThe Motley Fool • 06/03/25
Pfizer's BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal CancerBusiness Wire • 05/30/25
Collaborations for Change: AUA and Pfizer Select Recipients for $1.5 Million Grant Program to Improve Advanced Prostate Cancer CareGlobeNewsWire • 05/29/25
Hearing Against Pfizer Set For 30 May In Contraceptive ‘Depo-Provera' Multidistrict Litigation Overseen By Levin PapantonioBusiness Wire • 05/28/25
Investing In The Promising PD1/VEGF Bispecific - Pfizer And Instil Could Be Good CandidatesSeeking Alpha • 05/26/25
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a ResultThe Motley Fool • 05/24/25
Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate CancerPRNewsWire • 05/22/25